Eye

gGastro EHR 5.0 from Modernizing Medicine® Launches with a New User Experience that Further Speeds up Documentation

Data Management, Health, Technology, Practice Management, Other Health, Software, General Health, Modernizing Medicine, ASC, Elective surgery, Instagram, Efficiency, Health information management, Practice management, Podiatry, Pain management, Otorhinolaryngology, DO, Multimedia, Physician, Health, MD, Gastroenterology, LinkedIn, Twitter, Endoscopy, EMR, Ophthalmology, Medicine, EHR, HD, Documentation, UX, Dermatology, RCM, Blog, Chart, Eye, Hospital
Wednesday, September 22, 2021 - 5:00pm

Speeding up documentation, on average, by up to 20%, gGastro 5.0 helps doctors document patient health records more efficiently and improves staff communications and the patient experience.

Key Points: 
  • Speeding up documentation, on average, by up to 20%, gGastro 5.0 helps doctors document patient health records more efficiently and improves staff communications and the patient experience.
  • View the full release here: https://www.businesswire.com/news/home/20210922005834/en/
    The latest platforms user experience was designed to be highly intuitive, browser-agnostic, and faster than ever.
  • gGastro 5.0 delivers greater efficiencies with documentation by suggesting coding and using custom templates and Quick Notes in the Endoscopy Report Writer that can save gastroenterologists time.
  • The latest technologies are being deployed in waves reaching all existing Modernizing Medicine gGastro customers throughout the year.

Raiven Capital Invests in KnowWake, The Leading Marine Navigation Platform

Other Sports, Sports, General Sports, Maritime, Automotive, Finance, Consulting, Transport, Professional Services, Recreational Vehicles, Internet, Artificial intelligence, Lightspeed Venture Partners, Police, Series, Health, ICW, Intracoastal Waterway, Raiven, Environment, CEO, Growth, Silicon, Water, Founder, Technology, Capital, Safety, Eye, Cryptocurrency, Canal, Satellite navigation device
Wednesday, September 22, 2021 - 4:08pm

"Raiven Capital brings some of the brightest minds in venture capital from Silicon Valley. The follow-on investment from our initial investors is exciting as we are rapidly growing to meet user demand. Also, keep an eye out for the launch of our business portal -- just in time for the Fort Lauderdale International Boat Show in late October,” said Dan Karsko, CEO and Founder of KnowWake.

Key Points: 
  • Raiven Capital, a global early-stage venture fund, today announced its investment in KnowWake, the leading marine navigation platform for recreational boaters.
  • "Raiven Capital brings some of the brightest minds in venture capital from Silicon Valley.
  • Raiven Capital is a global early-stage Series A technology venture fund with roots in both Silicon Valley and Toronto.
  • Once growth is robust, Raiven exits its portfolio companies to later-stage capital in Silicon Valley and beyond.

Distinguished Psychologist And Addiction Specialist Joins Millennium Health Management Team

Policy, JAMA, CPE, Doctor of Philosophy, Cancer, Substance abuse, Multimedia, Patient, Drug overdose, Doctor of Pharmacy, University, Pain, SAN, Vanderbilt University, Sexual abuse, Research, Illegal drug trade, VP, University of Kentucky, Memorial Sloan Kettering Cancer Center, Eye, Industry, Bureau of Oceans and International Environmental and Scientific Affairs, Pharmaceutical industry
Wednesday, September 22, 2021 - 2:15pm

SAN DIEGO, Sept. 22, 2021 /PRNewswire/ --Specialty medication monitoring and drug testing company, Millennium Health today announced leading pain and addiction expert, Steven D. Passik, Ph.D. has joined its management team as VP, Scientific Affairs and Head of Clinical Data Programs.

Key Points: 
  • SAN DIEGO, Sept. 22, 2021 /PRNewswire/ --Specialty medication monitoring and drug testing company, Millennium Health today announced leading pain and addiction expert, Steven D. Passik, Ph.D. has joined its management team as VP, Scientific Affairs and Head of Clinical Data Programs.
  • Dr. Passik will focus primarily on expanding work begun at Millennium Health to inform clinicians, policy makers and public health officials about the changing landscape of substance abuse to help facilitate a data driven approach to this enormous public health problem.
  • "We are absolutely thrilled to have Dr. Passik become a part of our organization," said Angela G. Huskey, PharmD, CPE.
  • Millennium Health is an accredited specialty laboratory with over a decade of experience delivering timely, accurate, clinically-actionable information through our nationwide medication monitoring and drug testing services .

Akari Therapeutics to Present at the Cantor Virtual Global Healthcare Conference

Food, Therapy, BP, Failure, LTB4, Inflammation, Risk, Regulation of tobacco by the U.S. Food and Drug Administration, Annual report, European Medicines Agency, Conference, Private Securities Litigation Reform Act, Leukotriene, FDA, U.S. Securities and Exchange Commission, Thrombotic microangiopathy, Patient, Investor relations, Akari, Company, COVID-19, HIV disease progression rates, Leukotriene B4, TMA, Drug development, EMA, Intellectual property, Nasdaq, Eye, SEC, Lung, GLOBE, Pharmaceutical industry
Wednesday, September 22, 2021 - 2:00pm

NEW YORK and LONDON, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where complement (C5) and/or leukotriene (LTB4) systems are implicated, today announced that Clive Richardson, Chief Executive Officer, will present at the Cantor Virtual Global Healthcare Conference on Thursday, September 30, 2021 at 1:20 p.m.

Key Points: 
  • NEW YORK and LONDON, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where complement (C5) and/or leukotriene (LTB4) systems are implicated, today announced that Clive Richardson, Chief Executive Officer, will present at the Cantor Virtual Global Healthcare Conference on Thursday, September 30, 2021 at 1:20 p.m.
  • Investors interested in arranging a virtual meeting with the Company's management during the conference should contact the Cantor conference coordinator.
  • A webcast of the Companys presentation will be available by visiting Events in the Investor Relations section on the Companys website at www.akaritx.com .
  • We caution investors not to place considerable reliance on the forward-looking statements contained in this press release.

Aggreko to Light Up the Ryder Cup with 100 Generators, Battery Storage, and 65 Miles of Cable

Zero, Temperature, Whistling Straits, Ryder, Solution, Professional Golfers' Association of America, Carbon, Heat, PGA, Weather, Professional, Ryder Cup, Safety, United States, Electricity, CO2, Eye, GLOBE, Entertainment, Renewable energy
Wednesday, September 22, 2021 - 2:00pm

The Ryder Cup will take place from September 24-26, 2021, at Whistling Straits in Kohler, Wisconsin.

Key Points: 
  • The Ryder Cup will take place from September 24-26, 2021, at Whistling Straits in Kohler, Wisconsin.
  • To achieve this, Aggreko will install and operate 100 generators (23,000 kW of electricity), four 30 kW batteries, and over 65 miles of cable.
  • With an eye on sustainability, Aggreko is also instituting several innovative solutions to reduce the Ryder Cups carbon footprint and greenhouse gas emissions.
  • LED light balloons in place of traditional light towers will result in a further reduction of 160 metric tons of CO2.

BGG World Announces Completion of Astaxanthin Capacity Expansion and now has the World's Largest Astaxanthin Farm

AHS, GMP, BGG, Plant, Research, Multimedia, Astaxanthin, Athlete, Americas, CEO, Coronavirus, ISO9001, Beauty, Haematococcus pluvialis, Eye
Wednesday, September 22, 2021 - 1:52pm

IRVINE, Calif., Sept. 22, 2021 /PRNewswire/ -- BGG World (BGG) and its subsidiary Algae Health Sciences (AHS) announce the completion of a major capacity expansion of their state-of-the-art, 100% glass tube photobioreactor microalgae farm.

Key Points: 
  • IRVINE, Calif., Sept. 22, 2021 /PRNewswire/ -- BGG World (BGG) and its subsidiary Algae Health Sciences (AHS) announce the completion of a major capacity expansion of their state-of-the-art, 100% glass tube photobioreactor microalgae farm.
  • This farm is now the largest Astaxanthin farm in the world.
  • BGG was successful in completing this expansion over the last 18 months despite many challenges presented by the worldwide coronavirus epidemic.
  • "At BGG, we never want to leave any customer with unfulfilled or late orders, and we rarely do," said Chunhua Li, Chairman & Founder of BGG World.

Ocular Therapeutix™ Appoints Merilee Raines to Its Board of Directors

Biotechnology, Pharmaceutical, Optical, Health, Intraocular pressure, Duane syndrome, Certified Public Accountant, Compliance, Security (finance), Inflammation, Board of directors, Bowdoin College, NASDAQ, Private Securities Litigation Reform Act, FDA, U.S. Securities and Exchange Commission, Retina, AMD, Patient, Idexx Laboratories, Axitinib, IDXX, Prescription Drug User Fee Act, Board, Allergic conjunctivitis, Ocular hypertension, University, Company, Growth, Ophthalmology, Pain, COVID-19, PDUFA, Retirement, Laboratory, University of Chicago, NYSE, Eye, Pharmaceutical industry, Management
Wednesday, September 22, 2021 - 1:00pm

Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced the appointment of Merilee Raines to the Companys Board of Directors effective September 20, 2021.

Key Points: 
  • Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced the appointment of Merilee Raines to the Companys Board of Directors effective September 20, 2021.
  • We are excited to welcome Merilee to our Board of Directors, said Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutix.
  • Her guidance and input will be invaluable as we seek to grow Ocular into a strategic leader in the ophthalmology space.
  • Ms. Raines is also an experienced independent board director and currently serves as a member of the Board of Directors of Transmedics Group, Inc. (NASDAQ:TMDX), Watts Water Technologies, Inc. (NYSE:WTS) and Excelitas Technologies Corporation, a private company.

Woman-Owned Black Enterprise Marks 30 Years Helping Blue-Chip Companies and Elite Athletes Speak With Impact

EDT, Human, Nike, VHS, Fatigue, Cisco Systems, Sport, Microsoft, Hans Hassle, CommScope, Kaiser Permanente, Athlete, Environment, CEO, McDonald's, Child, Communication, Woman, Macdonald, Leadership, Washington Football Team, Fortune 500, Intel, Chief executive officer, Ubisoft, SVP, Eye, Industry, Travel, Super Bowl, Public relations, Fashion
Wednesday, September 22, 2021 - 12:25pm

For Denise Harrington, CEO and founder of Speaking With Impact , that first happened on stage at a major corporate business event in 1991.

Key Points: 
  • For Denise Harrington, CEO and founder of Speaking With Impact , that first happened on stage at a major corporate business event in 1991.
  • "Thirty years later, we have worked with dozens of companies, hundreds of executives, and thousands of professionals.
  • Who would have thought that 30 years ago a small, black, women-owned business, would become a force to be reckoned with in communications?"
  • One of her biggest clients, Nike, trusted her to work with their premier athletes to help them represent the brand with impact.

DVI And Neurolens Collaborate To Increase Prism Specificity

Technology, Optometry, Patient, Headache, Health, Master of Science, DVI, CONTOUR, Eye, SEER, Neurology, Prevalence, Reading, Reuters Digital Vision Program, Clinical research, Doctor of Philosophy, Industry, Telescopic sight, Pharmaceutical industry
Wednesday, September 22, 2021 - 12:00pm

This enhancement will cross all DVI platforms, including VISION Lab Management System, RxWizard, Web-based RxWizard and the SEER mobile app.

Key Points: 
  • This enhancement will cross all DVI platforms, including VISION Lab Management System, RxWizard, Web-based RxWizard and the SEER mobile app.
  • This expanded prism range will allow Neurolens providers to take advantage of the highly accurate measurements from the Neurolens Measurement Device, Gen 2 (NMD2) and prescribe precise prism measurements for their patients.
  • Neurolens designs are currently the only lens designs that can be ordered and manufactured to the 1/100th prism diopter on DVI platforms.
  • Bill Ball from DVI says, "For almost 40 years, DVI has been a recognized innovator and industry leader in Lab Management Software.

DGAP-News: Female-Led Supplement Brand, Reserveage, Launches Their First-Ever Topicals Offering with Pro-Collagen Skincare Line

Cream, Elasticity, Neck, Marketing, Hand, Instagram, Whole Foods Market, King Soopers, Vitamin Cottage Natural Grocers, Collection, Ageing, Periorbital puffiness, Pharmacy, Beauty, Industry, Face, Woman, Trial of the century, Technology, Personal care, Copper, TLC, Eye, MSRP, Skin, The Vitamin Shoppe, CVS Pharmacy, Fine chemical, Cosmetics
Wednesday, September 22, 2021 - 12:08pm

'When looking at the market opportunity, the skincare segment is the biggest and fastest-growing sector within the Beauty & Personal Care market,' said Yamit Sadok, Senior Director of Marketing at Reserveage.

Key Points: 
  • 'When looking at the market opportunity, the skincare segment is the biggest and fastest-growing sector within the Beauty & Personal Care market,' said Yamit Sadok, Senior Director of Marketing at Reserveage.
  • 'Reserveage as a brand is already positioned as a premium beauty brand with Collagen-boosting nutritionals targeting skin benefits.
  • We're excited to get products into the hands of consumers and make our official debut into the topical landscape.'
  • The new and innovative product line takes a unique approach to skincare that is designed for whole body benefits.